• Home
  • Free Medical Videos
  • Online Pharmacy
  • Ophthalmology
  • Gynecology and Obstetrics
Friday, September 26, 2025
  • Login
Meduweb
  • Home
  • Free Medical Videos
  • Online Pharmacy
  • Ophthalmology
  • Gynecology and Obstetrics
No Result
View All Result
  • Home
  • Free Medical Videos
  • Online Pharmacy
  • Ophthalmology
  • Gynecology and Obstetrics
No Result
View All Result
Meduweb
No Result
View All Result
Home Online Pharmacy

Probric syrup

Drug Index by Drug Index
June 4, 2019
in Online Pharmacy
419 9
0
Probric

Probric

277
SHARES
450
VIEWS
Share on FacebookShare on Twitter
Contents hide
1 Probric syrup composition:
2 Probric syrup properties:
3 Probric syrup pharmacokinetics:
4 Probric syrup indications:
5 Probric syrup dosage and administration:
6 Probric syrup side effects:
7 Probric syrup contra-indications:
8 Probric syrup precautions & warnings:
9 Probric syrup drug-drug interactions:
10 Probric syrup pregnancy and lactation:
11 Storage and presentation:
12 Produced by

Probric syrup composition:

Each 10 ml contains:
Bambuterol HCL .     10 mg

Probric
Probric syrup

Probric syrup properties:

Bambuterol is a prod rug of terbutaline, a direct-acting sympathomimetic with predominant beta-adrenergic activity. It selectively stimulates receptors, thus producing relaxation of bronchial smooth muscles, inhibition of the release of endogenous spasmogens, inhibition of oedema caused by endogenous mediators &
increased mucociliary clearance.

Probric syrup pharmacokinetics:

About 20% of an oral dose of bambuterol is absorbed. After absorption, bambuterol is slowly metabolized via hydrolysis (plasma-cholinesterase) and oxidation to active terbutaline. About 10% of the administered dose of Bambuterol is converted to terbutaline in adults. Children have a reduced clearance of terbutaline, but generate less terbutaline than adults. Therefore, children aged 6 – 12 years should be given adult doses, whereas smaller children (2 – 5 years) usually need less.
Due to differences in kinetics, oriental children should receive a low dose of bambuterol. Maximum plasma concentration of the active metabolite terbutaline is achieved within 2 to 6 hours. The duration of effect is at least 24 hours. Steady-state is achieved after 4 to 5 days of treatment. The plasma half-life of bambuterol after oral administration is about 13 hours. The plasma half-life of the active metabolite terbutaline is about 21 hours. Bambuterol and its metabolites, including terbutaline, are mainly excreted via the kidneys. Patients with renal failure and patients with severely impaired hepatic functions may display altered pharmacokinetics which would necessitate dose individualization.

Probric syrup indications:

Bronchial asthma, chronic bronchitis, emphysema & other lung diseases where bronchospasm is a complicating factor.

Probric syrup dosage and administration:

It should be used as maintenance therapy in asthma & other pulmonary diseases where bronchospasm is a complicating factor. Probric® is dosed once daily, preferably before bed-time. The dose should be individualized .
• Children 2-5years:
The recommended normal dose is 10 mg and because of difference in kinetics, 5 mg in oriental children.
Children 6-12 years :
The recommended initial dose is 10 mg, the dose may be increased to 20 mg after 1 to 2 weeks depending on clinical effect. Because of difference in kinetics, doses above 10 mg are not recommended in oriental children .
Adults & elderly:
Recommended initial dose is 10 mg. Dose may be increased to 20 mg after 1 to 2 weeks. In patients with impaired renal function, the recommended initial dose is 5 mg which may be increased to 10 mg after 1 to 2 weeks.

Probric syrup side effects:

– Adverse reactions which have been recorded are all characteristic of sympathomimetic amines. The intensity of the adverse is dose dependant. Tolerance to these effects has usually developed within 1 to 2 weeks.
– Common side effects are headache, palpitations, tachycardia, tremor, tonic muscle cramps, urticaria, & exanthema.
– Rare side effects include hypokalemia, nausea, sleep & behavioral disturbance such as agitation & restlessness.

Probric syrup contra-indications:

Hypersensitivity to any of the ingredients or to terbutaline.

Probric syrup precautions & warnings:

– Caution should be observed in patients with thyrotoxicosis and in patients with severe cardiovascular disorders. such as ischemic heart disease, tachyarrhythmias or severe heart failure.
– Due to the hyperglycemic effects of agonists, additional blood glucose monitoring is recommended initially in diabetic patients.
– Potentially serious hypokalemia may result from therapy. Particular caution is recommended in acute severe asthma as the associated risk may be augmented by hypoxia. The hypokalemic effect may be potentiated by concomitant treatments. It is recommended that serum potassium levels are monitored in such situations.

Probric syrup drug-drug interactions:

– Bambuterol prolongs the muscle relaxing effect of suxamethonium (succinyl choline) due to the fact that plasma cholinesterase which inactivates suxamethonium is partly inhibited by bambuterol. The inhibition is dose dependent & fully reversible after cessation of it.
– Beta-receptor blocking agents, especially those which are non-selective, may partly or totally inhibit the effect of beta-receplor stimulants.
– Hypokalemia may resull from therapy and may be potentiated by concomitant treatment with xanthine derivatives, steroids, and diuretics.

Probric syrup pregnancy and lactation:

–  There is no definite evidence of ill-consequence during pregnancy.
– Nevertheless, the drug should not be used during the first trimester of pregnancy, unless the expected benefit is thought to outweigh any possible risk to the fetus .
–  Terbutaline is excreted in the breast milk but an influence on the child is unlikely with therapeutic doses. However, caution is recommended when administered to breast feeding mothers.

Storage and presentation:

– Bottle of 125 ml.
– Store at a temperature below 30° C.
– Not to be used except under physician supervision.
Keep all medicaments out of reach of children

Produced by

BORS PHARMACEUTlCAlIND,
Borg EI-Arab new city -Industrial zone 3 – District 17 – Area no . 3 – Alexandria – Egypt

Tags: Bambuterol HCLbronchodilator
Drug Index

Drug Index

Search Videos

  • About
  • Privacy & Policy
  • Contact

© 2008-2019 Meduweb.

No Result
View All Result
  • Home
  • Free Medical Videos
  • Online Pharmacy
  • Ophthalmology
  • Gynecology and Obstetrics

© 2008-2019 Meduweb.

Welcome Back!

OR

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.Accept Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT

Add New Playlist